ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0972

Mapping Oligoclonally Expanded T Cells Within the Peripheral and Synovial Immune Landscape of Untreated ACPA+ Rheumatoid Arthritis Patients at the Single Cell Level

Pascale Wehr1, Hendrik Nel1, Chenhao Zhou2, Ahmed Mehdi2, Angelika Christ3, Helen Weedon4, Mihir Wechalekar5 and Ranjeny Thomas6, 1University of Queensland Diamantina Institute, Brisbane, Queensland, Australia, 2University of Queensland Diamantina Institute, Brisbane, Australia, 3University of Queensland Institute for Molecular Bioscience, Brisbane, Australia, 4Flinders Medical Centre, Adelaide, Australia, 5Flinders Medical Centre, Adelaide, South Australia, Australia, 6University of Queensland Diamantina Institute and Rheumatology Department, Princess Alexandra Hospital, Brisbane – Australia., Brisbane, Australia

Meeting: ACR Convergence 2020

Keywords: rheumatoid arthritis, T Cell

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: RA – Etiology & Pathogenesis (0970–0974)

Session Type: Abstract Session

Session Time: 3:00PM-3:50PM

Background/Purpose: Clonal T cell expansions – some large – have been identified in the peripheral blood (PB) and in synovial tissue (ST) of multiple joints from recently-diagnosed rheumatoid arthritis (RA) patients. As the degree of ST clonal dominance decreased with longer disease duration, new-onset RA presents the ideal opportunity to study the transcriptome and TCRα/β of individual clonotypes. This can be achieved using single-cell RNA-sequencing, which already identified novel T cell subsets in longstanding RA. To elucidate the TCR usage and transcriptome of oligoclonally expanded T cells in the PB and ST compartments in newly-diagnosed RA, we combined TCR repertoire, clonality and transcriptomic analysis of individual ST and paired PB mononuclear cells (PBMC) in untreated HLA-DRB1*0401+ ACPA+ RA patients.

Methods: PBMC and whole cryopreserved ST samples were collected from 4 treatment-naïve RA patients undergoing arthroscopic synovial biopsy. CD45+ leukocytes from cryopreserved PBMC, and CD45+ leukocytes and CD45– fibroblasts isolated from paired disaggregated ST, by fluorescence-activated cell sorting, were sequenced using 5’ RNA/TCR single-cell 10x Genomics kits. Single-cell transcriptomic analysis, using the Seurat package in R, reconstructed the compartment-specific composition of PB and ST.

Results: Myeloid cells were expanded in the ST relative to PB. Myeloid and NK cell expansion was related to arthroscopic synovitis severity. NK and B cell clusters were proportionately smaller among ST than PB leukocytes. Transcriptomics identified 10 unique CD3+TCR+ populations in PB and ST, including cytotoxic, helper and regulatory T cells. In PB, the most expanded clonotypes were CD8+ and CD4+ cytotoxic T cells. ST expanded clonotypes included CD8+ and CD4+ T cells expressing cytotoxic and multiple cytokine genes, CD4+ICOS+ T cells with evidence of IL-6 signalling, and CD4+GATA3+ tissue-resident T cells. Shared ST and PB T cell clonotypes were predominantly cytotoxic polyfunctional CD8+ T cells. A proportion of PB cytotoxic clonotypes matched known EBV and CMV-reactive clones, and a proportion of shared PB/ST cytotoxic clonotypes matched CMV-reactive clones.

Conclusion: Similar T cell clusters were identified in ST and PB. Transcriptomes of non-cytotoxic expanded CD4+ T cell clonotypes in the ST of untreated patients suggest B cell interaction and help. The most expanded clonotypes in circulation include T cells with cytotoxic and proinflammatory capability, including known viral-specific clones, some of which reach and expand in RA ST. Antigen derived and presented from persistent viruses may expand responsive clones to be bystander drivers of synovial inflammation.


Disclosure: P. Wehr, None; H. Nel, None; C. Zhou, None; A. Mehdi, None; A. Christ, None; H. Weedon, None; M. Wechalekar, Janssen Research Philadelphia USA, 2; R. Thomas, Abbvie, 8, BMS, 5, 8, Janssen-Cilag, 8.

To cite this abstract in AMA style:

Wehr P, Nel H, Zhou C, Mehdi A, Christ A, Weedon H, Wechalekar M, Thomas R. Mapping Oligoclonally Expanded T Cells Within the Peripheral and Synovial Immune Landscape of Untreated ACPA+ Rheumatoid Arthritis Patients at the Single Cell Level [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/mapping-oligoclonally-expanded-t-cells-within-the-peripheral-and-synovial-immune-landscape-of-untreated-acpa-rheumatoid-arthritis-patients-at-the-single-cell-level/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mapping-oligoclonally-expanded-t-cells-within-the-peripheral-and-synovial-immune-landscape-of-untreated-acpa-rheumatoid-arthritis-patients-at-the-single-cell-level/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology